{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:41:01Z","timestamp":1789839661132,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2015JJ2082"],"award-info":[{"award-number":["2015JJ2082"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["CX2014B295"],"award-info":[{"award-number":["CX2014B295"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["13JJ1022\/S2013J5050"],"award-info":[{"award-number":["13JJ1022\/S2013J5050"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31270819"],"award-info":[{"award-number":["31270819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation of Hunan Provincial Education Department of China","award":["15A086"],"award-info":[{"award-number":["15A086"]}]},{"DOI":"10.13039\/501100008959","name":"Hunan Agricultural University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008959","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.02.047","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T19:14:33Z","timestamp":1456686873000},"page":"1896-1903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B"],"prefix":"10.1016","volume":"34","author":[{"given":"Gaowei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.047_bib0280","first-page":"99","article-title":"Fast single-Use VLP vaccine productions based on insect cells and the baculovirus expression vector system: influenza as case study","volume":"138","author":"Eibl","year":"2014","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design","volume":"38","author":"Bessa","year":"2008","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.047_bib0290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"23","key":"10.1016\/j.vaccine.2016.02.047_bib0295","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.vaccine.2011.03.067","article-title":"H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2011.02.006","article-title":"Current strategies for subunit and genetic viral veterinary vaccine development","volume":"157","author":"Brun","year":"2011","journal-title":"Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2016.02.047_bib0305","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.047_bib0310","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rvsc.2011.10.018","article-title":"Virus-like particles: potential veterinary vaccine immunogens","volume":"93","author":"Liu","year":"2012","journal-title":"Res Vet Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.047_bib0315","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1007\/s00705-014-2178-0","article-title":"Chimeric influenza-virus-like particles containing the porcine reproductive and respiratory syndrome virus GP5 protein and the influenza virus HA and M1 proteins","volume":"159","author":"Xue","year":"2014","journal-title":"Arch Virol"},{"issue":"49","key":"10.1016\/j.vaccine.2016.02.047_bib0320","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1016\/j.vaccine.2012.09.048","article-title":"Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein","volume":"30","author":"Wang","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.02.047_bib0325","first-page":"2601","article-title":"Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer","volume":"25","author":"Tegerstedt","year":"2005","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.vaccine.2016.02.047_bib0330","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/14712598.7.7.997","article-title":"Vaccination: immune and gene therapy based on virus-like particles against viral infections and cancer","volume":"7","author":"Ramqvist","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.047_bib0335","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/14712598.2011.583914","article-title":"Human JC virus-like particles as a gene delivery vector","volume":"11","author":"Chang","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0340","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2010.01.018","article-title":"Recent advances in the epidemiology: diagnosis and control of diseases caused by porcine circovirus type 2","volume":"187","author":"Grau-Roma","year":"2011","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.meegid.2013.06.017","article-title":"Molecular analysis of porcine circovirus type 2 strains from Uruguay: evidence for natural occurring recombination","volume":"19","author":"Ramos","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2016.02.047_bib0350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.virusres.2011.11.001","article-title":"Molecular interactions of porcine circoviruses type 1 and type 2 with its host","volume":"164","author":"Mankertz","year":"2012","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.047_bib0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetmic.2003.10.014","article-title":"Molecular biology of porcine circovirus: analyses of gene expression and viral replication","volume":"98","author":"Mankertz","year":"2004","journal-title":"Vet Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.047_bib0360","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00253-012-4015-2","article-title":"Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development","volume":"95","author":"Wu","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0365","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1743-422X-7-166","article-title":"Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli","volume":"7","author":"Yin","year":"2010","journal-title":"Virol J"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.047_bib0370","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s10529-015-1856-7","article-title":"Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers","volume":"37","author":"Liu","year":"2015","journal-title":"Biotechnol Lett"},{"issue":"42","key":"10.1016\/j.vaccine.2016.02.047_bib0375","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2009.07.061","article-title":"The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts","volume":"27","author":"Bucarey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0380","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jviromet.2014.07.021","article-title":"Secretory expression of porcine circovirus type 2 capsid protein in Pichia pastoris","volume":"207","author":"Silva","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbiotec.2014.04.006","article-title":"The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development","volume":"181","author":"Chi","year":"2014","journal-title":"J Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.02.047_bib0390","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11259-007-3469-7","article-title":"Immunogenicity of empty capsids of porcine circovius type 2 produced in insect cells","volume":"31","author":"Fan","year":"2007","journal-title":"Vet Res Commun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.02.047_bib0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetmic.2012.11.045","article-title":"Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin","volume":"163","author":"Li","year":"2013","journal-title":"Vet Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.02.047_bib0400","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/v6124839","article-title":"Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes","volume":"6","author":"Zhang","year":"2014","journal-title":"Viruses"},{"issue":"15","key":"10.1016\/j.vaccine.2016.02.047_bib0405","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J Virol"},{"issue":"5686","key":"10.1016\/j.vaccine.2016.02.047_bib0410","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/276368a0","article-title":"Tomato bushy stunt virus at 2.9 A resolution","volume":"276","author":"Harrison","year":"1978","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.047_bib0415","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/JVI.76.9.4241-4250.2002","article-title":"Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain","volume":"76","author":"Ostrowski","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0420","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vetimm.2004.09.005","article-title":"Role of neutralizing antibodies in PRRSV protective immunity","volume":"102","author":"Lopez","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4049\/jimmunol.159.1.279","article-title":"Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope","volume":"159","author":"Garrity","year":"1997","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0430","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11262-010-0453-z","article-title":"Genomic analysis of two Chinese strains of porcine reproductive and respiratory syndrome viruses with different virulence","volume":"40","author":"Li","year":"2010","journal-title":"Virus Genes"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0435","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00411-15","article-title":"Complete genome sequence of porcine circovirus strain 102 with a novel mutation, isolated from hunan province, China","volume":"3","author":"Zhu","year":"2015","journal-title":"Genome Announc"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.047_bib0440","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00705-013-1612-z","article-title":"Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus","volume":"158","author":"Nam","year":"2013","journal-title":"Arch Virol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2016.02.047_bib0445","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1099\/vir.0.80652-0","article-title":"Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4\/31","volume":"86","author":"Misinzo","year":"2005","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0450","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/JVI.01229-07","article-title":"Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells","volume":"82","author":"Misinzo","year":"2008","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2016.02.047_bib0455","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1128\/JVI.01406-12","article-title":"Complete genome sequence of porcine circovirus 2b strain CC1","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol"},{"issue":"3-4","key":"10.1016\/j.vaccine.2016.02.047_bib0460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","article-title":"Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs","volume":"125","author":"Fort","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0465","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12896-014-0100-1","article-title":"Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies","volume":"14","author":"Nainys","year":"2014","journal-title":"BMC Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.02.047_bib0470","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.vaccine.2008.11.011","article-title":"Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge","volume":"27","author":"Haynes","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.047_bib0475","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4161\/hv.23900","article-title":"Prospects for prophylactic hepatitis C vaccines based on virus-like particles","volume":"9","author":"Beaumont","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10.1016\/j.vaccine.2016.02.047_bib0480","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1128\/JVI.01123-15","article-title":"Modification of asparagine-linked glycan density for the design of hepatitis B virus virus-like particles with enhanced immunogenicity","volume":"89","author":"Hyakumura","year":"2015","journal-title":"J Virol"},{"issue":"29","key":"10.1016\/j.vaccine.2016.02.047_bib0485","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.vaccine.2015.05.016","article-title":"Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein: L2","volume":"33","author":"Tumban","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0490","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13104-015-1780-x","article-title":"EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge","volume":"9","author":"Wang","year":"2016","journal-title":"BMC Res Notes"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0495","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2012.09.019","article-title":"Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency","volume":"96","author":"Mohana Subramanian","year":"2012","journal-title":"Antiviral Res"},{"issue":"46","key":"10.1016\/j.vaccine.2016.02.047_bib0500","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"issue":"3-4","key":"10.1016\/j.vaccine.2016.02.047_bib0505","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2012.04.026","article-title":"Virus-like particles: the new frontier of vaccines for animal viral infections","volume":"148","author":"Crisci","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.047_bib0510","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1128\/JVI.02294-10","article-title":"Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs","volume":"85","author":"Beach","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.047_bib0515","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2015.11.005","article-title":"Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus","volume":"213","author":"Pineyro","year":"2015","journal-title":"Virus Res"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2016.02.047_bib0520","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1099\/0022-1317-81-7-1815","article-title":"Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes","volume":"81","author":"Mahe","year":"2000","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.02.047_bib0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetmic.2011.11.030","article-title":"Antigenic subtyping and epitopes\u2019 competition analysis of porcine circovirus type 2 using monoclonal antibodies","volume":"157","author":"Saha","year":"2012","journal-title":"Vet Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.02.047_bib0530","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2460\/javma.2005.226.1707","article-title":"Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herds","volume":"226","author":"Lowe","year":"2005","journal-title":"J Am Vet Med Assoc"},{"issue":"1-3","key":"10.1016\/j.vaccine.2016.02.047_bib0535","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetmic.2007.02.009","article-title":"Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge","volume":"123","author":"Zuckermann","year":"2007","journal-title":"Vet Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.047_bib0540","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/CVI.00304-06","article-title":"Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent","volume":"14","author":"Lopez","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.047_bib0545","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rvsc.2014.04.007","article-title":"Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines","volume":"97","author":"Seo","year":"2014","journal-title":"Res Vet Sci"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.02.047_bib0550","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2015.02.027","article-title":"Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b","volume":"177","author":"Jeong","year":"2015","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T02:03:17Z","timestamp":1692237797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":55,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16002280"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}